The number of lawsuits filed against Gilead Sciences due to their TDF HIV medicines has grown. The plaintiffs claim that Gilead deliberately delayed the development of a safer HIV medication, despite the fact that scientists had already developed a better treatment in 2000. The lawsuit outlines the specific reasons why Gilead should be held accountable. Here are a few of these reasons. All of them are glaringly unfair.
In April 2016, the AIDS Healthcare Foundation filed a lawsuit against Gilead claiming that the company manipulated the patent system to delay the development of safer TAF medications. This lawsuit exposed Gilead’s bald-faced greed, and showed how it had delayed research and development of a safer form of TDF while still charging high prices. The lawsuit also asked the court to invalidate Gilead’s TDF patents, which essentially protects the new medicine from competition. In response, Gilead argued that the lawsuits did not prove that they illegally manipulated the patent system.
The Gilead Sciences TDF Lawsuit filed against Gilead allege that the company failed to warn patients of the risk of TDF side effects. In addition, the lawsuit claims that Gilead failed to disclose the risks of the TDF drug to consumers, and failed to release an alternative that was safer. These claims have a high likelihood of success, so if you have suffered from the ailment caused by TDF, you should consider filing a lawsuit against the company.
As the lawsuit relates to HIV drugs, the company is guilty of failure to warn patients of the serious side effects of TDF and failed to provide them with an adequate alternative. The drug’s bioavailability is low, which means it is not easily absorbed. The high doses of TDF can also cause kidney and bone toxicity. This is the primary reason why Gilead stopped research and development of TDF in 2004, but delayed the introduction of the newer medications until the patents for TAF and Rifampin expire.
Because Gilead’s HIV business is based on HIV drugs, the company has largely failed to produce any viable alternative. Despite its huge portfolio of assets, Gilead has faced numerous risks and lawsuits. The latest TDF lawsuits have increased Gilead’s risk profile and are a reason to seek a settlement with the company. So what can you do to help protect yourself?
As a result of the lack of an alternative, the company delayed the release of safer HIV drugs, such as TAF. The newer HIV drugs would have been a much safer option. Gilead failed to provide patients with proper warnings about the drug’s risks and delayed its introduction. This prompted the filing of at least 140 lawsuits and compensation for bone and kidney injuries caused by TDF.